ORG Wealth Partners
ASND icon

ORG Wealth Partners’s Ascendis Pharma A/S ASND Stock Holding History

ORG Wealth Partners’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.06K Sell
31
-25
-45% -$6.33K ﹤0.01% 825
2026
Q2 		$14.9K Hold
56
– – ﹤0.01% 479
2026
Q1 		$12.8K Buy
56
+29
+107% +$6.5K ﹤0.01% 469
2025
Q4 		$5.76K Buy
27
+2
+8% +$413 ﹤0.01% 506
2025
Q3 		$4.97K Hold
25
– – ﹤0.01% 522
2025
Q2 		$4.3K Buy
+25
New +$4.07K ﹤0.01% 560

Other funds holding ASND

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
ARS Investment Partners
ARS Investment Partners New York $2.23B AUM 74.02% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Braun Stacey Associates
Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

ORG Wealth Partners's ASND Position: Q3 2026 in Review

ORG Wealth Partners reduced its Ascendis Pharma A/S (ASND) stake by 45% in Q3 2026, selling an estimated $6.33K and leaving 31 shares worth $7.06K. The position accounts for ﹤0.01% of the portfolio, ranked #825.

ORG Wealth Partners first reported a position in ASND in Q2 2025 and has held it in 6 quarters since. The position peaked at $14.9K in Q2 2026. 123 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • ORG Wealth Partners held 31 shares of Ascendis Pharma A/S worth $7.06K as of Q3 2026.
  • ORG Wealth Partners sold 25 Ascendis Pharma A/S shares in Q3 2026, an estimated $6.33K.
  • Ascendis Pharma A/S made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #825 holding.
  • ORG Wealth Partners first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 6 quarters since.
  • ORG Wealth Partners's Ascendis Pharma A/S position peaked at $14.9K in Q2 2026.
  • 123 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.